Chair Rodgers Opening Statement at Health Markup of 23 Legislative Proposals

Energy & Commerce GOP
48 followers
May 17, 2024
The Committee on Energy and Commerce is the oldest standing legislative committee (established 1795) in the U.S. House of Representatives and is vested with the broadest jurisdiction of any congressional authorizing committee. The Energy and Commerce Committee is at the forefront of all issues and policies powering America’s economy, including our global competitive edge in energy, technology, and health care. The committee is led by E&C Chair Cathy McMorris Rodgers (R-WA) and E&C Ranking Member Frank Pallone (D-NJ).
E&C Website: https://energycommerce.house.gov
E&C Twitter: https://twitter.com/HouseCommerce
E&C Facebook: https://www.facebook.com/energyandcommerce/
E&C Instagram: https://www.instagram.com/energyandcommerce/
committee chair Rogers for 5 minutes for
an opening statement good morning thank
you chair Guthrie today we consider
bipartisan legislation to extend teleah
health flexibilities that are set to
expire at the end of the year while
continuing these flexibilities for
seniors will require an investment by
Congress it is crucial that we continue
to allow seniors to access health care
via tah Health if they choose the bills
we are considering today will protect
seniors access to teleah health for an
additional two years they improve upon
the bipartisan work of past congresses
by adding new program integrity
safeguards and some of the bills will
also expand how seniors can benefit from
telea health I commend Representatives
Carter Joyce Alderson James Bill arus
and many other members on both sides of
the aisle for their continued hard work
on advancing these policies teleah
Health has proven to be vital for
patients across the country especially
in rural areas like my district in
Eastern Washington I look forward to
advancing legislation today and and am
committed to continuing working to
address any outstanding concerns and to
ensuring the legislation is fully paid
for before we consider them at the full
committee I'm also pleased that we're
considering several bipartisan bills to
support and build upon efforts to
increase access to care raise awareness
and improve coordination across our
federal government for programs related
to autism and lung cancer lastly the
committee is working on on a six-year
reauthorization of the rare pediatric
disease priority review Voucher Program
ahead of its September 30th expiration
we've heard testimony on the importance
of this program and this week de the
Dion family has been meeting with
offices to share their story when Peter
and Maggie Dion were born they were each
discharged from the hospital with a
clean bill of health and initially
seemed to be hitting their development
Al Milestones Peter loved to fish for
tuna with his dad Maggie enjoyed dance
and running with her
mom everything changed when Peter was
almost 10 and was struggling to climb up
a set of stairs Peter was diagnosed with
a form of muscular distrophy limb girdle
type 2 C later that year then his
six-year-old sister Maggie was also
diagnosed with the same disease
this type of muscular distrophy is a
rapidly progressive muscle wasting
disease and there is currently no cure
as their father put it there are so many
genetic variations doctors ran out of
letters in the alphabet to identify the
condition the prevalence of the disease
is low as is and with near and with over
30 subtypes of the disease each
requiring a different Gene replacement
therapy spurring the much needed
research and development proves
challenging without additional
incentives without the rare pediatric
disease priority review Voucher Program
Maggie and Peter's parents say their
chances of getting treatments for their
kids almost becomes
impossible for anyone who doubts why
this program is needed I urge you to
consider the Dion family and their story
and sadly it is a story known to many
families just this week the National
Organization of rare diseases which
represents patients with rare diseases
and their families released analysis of
the importance of the prv program it is
clear from their analysis that the
program is successful but the report
also provides important insights on how
long it can take to see that success
drugs take years and hundreds of
millions or even billions of dollars to
develop while the rare pediatric prv
program was started in 202 12 more than
half of the designations Awards and
voucher redemptions came in the last
four years I want to thank Mr Bill
arachis Miss ESU and many others for
their work on the rare disease
legislation being considered
today these bills will strengthen the
orphan drug pathway make sure drugs are
studied for children battling cancer and
continue the important prv program I'm
proud of all the work and patient voices
reflected in the legislation before us I
also know that more can and should be
done this subcommittee has heard
testimony on many other proposals such
as my legislation to improve access to
Home and Community Based Services in
Medicaid and I look forward to
continuing to work with members to move
those forward in the future thank you
and I yield back the chair
